Thompson Tommy G
Transaction: 12/23/2025
BUY
Change
+8,400
Price
$1.67
Filing
12/29/2025
Type
BUY
TherapeuticsMD, Inc.
TXMD • Drug Manufacturers - Specialty & Generic
$2.21
▼ -0.03 (-1.34%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$25.73M
Growth
-2.8%
Cash Flow
2/5
Trend
Volatile
Evidence
Positive free cash flow · 0.21Manageable debt level · 0.19Healthy liquidity · 3.02Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 19, 2026, 12:17 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$2.21
Change-1.34%
Shares Out11.64M
Market Cap$25.73M
Enterprise Value$21.06M
52W Range0.99 - 2.95
Beta0.64
P/E-118.58
P/S10.72
P/B0.95
P/FCF8.20
EV/Sales8.77
Price$2.21
Change-1.34%
Shares Out11.64M
Market Cap$25.73M
Enterprise Value$21.06M
52W Range0.99 - 2.95
Beta0.64
P/E-118.58
P/S10.72
P/B0.95
P/FCF8.20
EV/Sales8.77
EV/EBITDA-6.52
EV/FCF6.71
Earnings Yield-0.84%
FCF Yield12.19%
Dividend Yield0.00%
Gross Margin100.00%
Oper. Margin-139.44%
Profit Margin-18.83%
Debt/Eq0.19
Current Ratio3.02
Quick Ratio3.02
Revenue 5Y-2.81%
Volume27.73K
Avg Volume33.24K
EPS Surprise6.14
Investment DNA
How strong this company looks for long-term investors
51
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
58/100
Price Attractiveness
Cheap or expensive today
80/100
Why this score▼
Positive free cash flow · 0.21Manageable debt level · 0.19Healthy liquidity · 3.02Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 8 analyst votes · 2026-09-05
69/100
Neutral
Bullish
4
Hold
3
Bearish
1
Insider Transactions
Recent executive and insider activity
Walker Marlan D
Transaction: 11/03/2025
BUY
Change
+67,492
Price
$1.15
Filing
11/05/2025
Type
BUY
Collins Cooper C.
Transaction: 11/03/2025
BUY
Change
+8,500
Price
Not reported
Filing
11/05/2025
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Thompson Tommy G | BUY | +8,400 | $1.67 | 12/23/2025 | 12/29/2025 |
| Walker Marlan D | BUY | +67,492 | $1.15 | 11/03/2025 | 11/05/2025 |
| Collins Cooper C. | BUY | +8,500 | Not reported | 11/03/2025 | 11/05/2025 |
| Naughton Gail K | BUY | +8,500 | Not reported | 11/03/2025 | 11/05/2025 |
| Thompson Tommy G | BUY | +8,500 | Not reported | 11/03/2025 | 11/05/2025 |
| Walker Marlan D | BUY | +490 | $1.00 | 04/14/2025 | 04/15/2025 |
| Thompson Tommy G | BUY | +325 | $1.00 | 04/14/2025 | 04/15/2025 |
| Walker Marlan D | BUY | +1,167 | $0.86 | 04/10/2025 | 04/10/2025 |
| Walker Marlan D | BUY | +1,136 | $0.87 | 04/09/2025 | 04/10/2025 |
| Walker Marlan D | SELL | -3,467 | Not reported | 02/18/2025 | 02/20/2025 |
| Walker Marlan D | SELL | -770 | Not reported | 02/18/2025 | 02/20/2025 |
| Walker Marlan D | BUY | +3,467 | Not reported | 02/18/2025 | 02/20/2025 |
| Thompson Tommy G | SELL | -8,500 | Not reported | 02/18/2025 | 02/20/2025 |
| Thompson Tommy G | BUY | +8,500 | Not reported | 02/18/2025 | 02/20/2025 |
| Naughton Gail K | SELL | -8,500 | Not reported | 02/18/2025 | 02/20/2025 |
| Naughton Gail K | BUY | +8,500 | Not reported | 02/18/2025 | 02/20/2025 |
| Collins Cooper C. | SELL | -8,500 | Not reported | 02/18/2025 | 02/20/2025 |
| Collins Cooper C. | BUY | +8,500 | Not reported | 02/18/2025 | 02/20/2025 |
| Collins Cooper C. | BUY | +4,094 | $1.73 | 08/22/2024 | 08/26/2024 |
| Collins Cooper C. | BUY | +1,200 | $1.70 | 08/21/2024 | 08/23/2024 |